RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC.
0.7846
-0.004 -0.510%
Share volume: 250,196
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.79
0.00
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 7.922 M | 8.130 M | 8.463 M | |
| Selling general and admin | 2.138 M | 2.545 M | 1.604 M | |
| Research and development | 5.784 M | 5.584 M | 6.858 M | |
| Total expenses | 7.922 M | 8.130 M | 8.463 M | |
| 2.62% | 4.09% | |||
| Operating income | -7.922 M | -8.130 M | -8.463 M | |
| Ebit | -7.596 M | -7.935 M | -8.414 M | |
| Pretax income | -7.426 M | -7.853 M | -8.366 M | |
| 5.74% | 6.54% | |||
| Income tax | 7.396 K | 7.385 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -7.434 M | -7.860 M | -8.366 M | |
| -5.73% | -6.44% |
